From a Cell's Viewpoint: Targeting Mitochondria in Alzheimer's disease
Emily Ann Carlson1, Valasani Koteswara Rao1, Shirley ShiDu Yan1
1Department of Pharmacology & Toxicology and Higuchi Biosciences Center, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, USA.
Drug Discovery Today. Therapeutic Strategies
|January 6, 2015
Summary
Mitochondria are vital cell components involved in metabolism and cell survival. Targeting mitochondrial processes may offer new therapeutic strategies for diseases like Alzheimer's disease.
Area of Science:
- Cellular Biology
- Mitochondrial Biology
- Neuroscience
Background:
- Mitochondria are crucial cellular organelles involved in energy production, signaling, and cell maintenance.
- Mitochondrial dysfunction is implicated in various diseases, notably Alzheimer's disease.
- Understanding mitochondrial roles is key to comprehending cellular operations.
Purpose of the Study:
- To highlight the significance of mitochondria in cellular health and disease.
- To explore the potential of targeting mitochondrial processes for therapeutic interventions.
- To underscore the relevance of mitochondrial research in neurodegenerative diseases.
Main Methods:
- Literature review on mitochondrial functions.
- Analysis of the role of mitochondria in disease pathogenesis.
- Exploration of therapeutic strategies targeting mitochondria.
Main Results:
- Mitochondria play multifaceted roles in cellular metabolism and survival.
- Mitochondrial dysfunction contributes to the progression of various pathologies.
- Targeting specific mitochondrial pathways presents a promising therapeutic avenue.
Conclusions:
- Mitochondria are central to cellular function and disease development.
- Therapeutic strategies focused on mitochondria could offer novel treatment options for diseases like Alzheimer's.
- Further research into mitochondrial biology is essential for advancing medical treatments.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:46Electron Transport Chain: Complex I and II
19.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:23Alzheimer Disease ll: Pathophysiology
1
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1
01:37Mitochondria
21.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.7K
01:29Alzheimer Disease l: Introduction
2
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
2